SCHEMBL16638603

SCHEMBL16638603

CCOC(=O)/C(C)=C/c1cc(F)c(Oc2ccc(S(=O)(=O)NC)cc2)c(F)c1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC9A3 P48764 13/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24380143 0.91 SLC9A3 (0.54) SLC9A3
SCHEMBL13276135 0.89 SLC9A3 (0.57) SLC9A3
SCHEMBL13276136 0.89 SLC9A3 (0.57) SLC9A3
SCHEMBL7651694 0.87 SLC9A3 (0.48) SLC9A3
SCHEMBL7023341 0.87 SLC9A3 (0.48) SLC9A3
SCHEMBL13286043 0.87 SLC9A3 (0.46) SLC9A3
SCHEMBL13449814 0.86 SLC9A3 (0.69) SLC9A3
SCHEMBL7032792 0.86 SLC9A3 (0.55) SLC9A3
SCHEMBL13449818 0.86 SLC9A3 (0.69) SLC9A3
SCHEMBL2575299 0.85 SLC9A3 (0.49) SLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006281-B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders ARDELYX, INC. (US) 2015-04-14 — — US disclosed
Send feedback